|On-Demand Substance Abuse Webinars|
Activities are listed chronologically, with the most recent releases listed first. Please review all activities to find those most applicable to you and your practice!
Addressing Pennsylvania's Opioid Crisis: What the Health Care Team Needs to Know (5 Part Series)
This CE series is a collaboration between numerous groups including the Pennsylvania Pharmacists Association, the Pennsylvania Medical Society, the Pennsylvania State Nurses Association, the Pennsylvania Department of Health, and others. The modules cover a variety of tools and resources for prescribers and dispensers to better address opioid addiction with their patients.
Target Audience: Pharmacists and Pharmacy Technicians
CE Credit: 5 modules totaling 4.25 hours
Putting the Fire Out: Intranasal Naloxone and The Emerging Role of the Pharmacist
Death from opioid overdoses is a growing epidemic in the United States, with deaths having more than tripled since 1999. Naloxone, a pure opioid antagonist, has been hypothesized as a possible agent to combat this epidemic. When administered intranasally, naloxone has been shown to be as effective as the intravenous route. This formulation, as well as the recent passing of PA Act 139, has also allowed for simple mass distribution across Pennsylvania. Despite these allowances, myths and controversies surrounding this agent, as well as the role of the pharmacist, exist. This continuing education session will describe the current opioid epidemic and the role of intranasal naloxone. It will also review the current literature base surrounding the use of intranasal naloxone and trends in opioid abuse, and finally describe the role of the pharmacist in dispensing intranasal naloxone.
Target Audience: All Pharmacists
CE Credit: 1.5 hours
Presenters: Karen Steinmetz Pater, PharmD, BCPS, CDE, Assistant Professor, University of Pittsburgh School of Pharmacy, Department of Pharmacy and Therapeutics; Jennifer Pruskowski, PharmD, BCPS, CGP, CPE, Assistant Professor, University of Pittsburgh School of Pharmacy, Department of Pharmacy and Therapeutics
The Pennsylvania Naloxone Prescription Standing Order for Overdose Prevention: Implications on Community Pharmacy Practice
Heroin and opioid overdose are the leading cause of accidental death in Pennsylvania. In October of 2015, Governor Tom Wolf announced a statewide naloxone standing order for overdose prevention, signed by Physician General Dr. Rachel Levine. This program will outline the components of this newly signed standing order as well as discuss best practices for implementation within the community pharmacy setting. Proper device use will be displayed and patient/eligible person (those in a position to assist a person at risk of experiencing an opioid-related overdose) education will be discussed.
Target Audience: All pharmacists
CE Credit: 1 hour
Presenters: John DeJames, RPh, Manager of Clinical Programs - Special Projects, Giant Eagle Pharmacy; Christine Jordan, PharmD, Clinical Coordinator, Giant Eagle Pharmacy; Jessica N. Sikora, PharmD, PGY1 Community Practice Resident, Duquesne University/Giant Eagle Pharmacy